Affiliation:
1. Division Family Medicine and Primary Care, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch 7602, South Africa
Abstract
Background: Drug-resistant tuberculosis (DR-TB) continues to challenge global efforts toward eradicating and having a tuberculosis-free world. Considering the high early mortality, especially among HIV-infected individuals, early diagnosis and prompt initiation of effective treatment are needed to significantly reduce mortality and halt transmission of DR-TB in the community. Aim: This study aims to assess the effectiveness of a community DR-TB care model with the specific objective of determining the Time-to-treatment initiation of DR-TB among patients in the OR Tambo district municipality. Methods: A prospective cohort study of patients with DR-TB was conducted in the OR Tambo district municipality of Eastern Cape Province, South Africa. Patients were enrolled as they presented for treatment initiation at the decentralised facilities following a diagnosis of DR-TB and compared with a centralised site. Results: A total of 454 DR-TB patients from six facilities between 2018 and 2020 were included in the analysis. The mean age was 37.54 (SD = 14.94) years. There were slightly more males (56.2%) than females (43.8%). Most of the patients were aged 18–44 years (67.5%), without income (82.3%). Results showed that slightly over thirteen percent (13.4%) of patients initiated treatment the same day they were diagnosed with DR-TB, while 36.3% were on the time-to-treatment target of being initiated within 5 days. However, about a quarter (25.8%) of patients failed to initiate treatment two weeks after diagnosis. Time-to-treatment initiation (TTTI) varied according to the decentralised sites, with progressive improvement with each successive year between 2018 and 2021. No demographic factor was significantly associated with TTTI. Conclusion: Despite rapid diagnosis, only 36% of patients were initiated on treatment promptly. Operational challenges remained, and services needed to be reorganised to maximise the exceptional potentials that a decentralised community DR-TB care model brings.
Funder
National Research Foundation
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference52 articles.
1. World Health Organization (2020). Global Tuberculosis Report, World Health Organization. Available online: https://www.who.int/publications/i/item/9789240013131.
2. Erasing the world’s slow stain: Strategies to beat multidrug-resistant tuberculosis;Dye;Science,2002
3. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis;Dharmadhikari;Int. J. Tuberc. Lung Dis.,2014
4. Decentralized, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience;Daru;Glob. Health Sci. Pract.,2018
5. Hanrahan, C.F., Dorman, S.E., Erasmus, L., Koornhof, H., Coetzee, G., and Golub, J.E. (2012). The impact of expanded testing for multidrug resistant tuberculosis using geontype MTBDRplus in South Africa: An observational cohort study. PLoS ONE, 7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献